_edited.png)
RISK CONCERN
Investment Strategy, Risk Analysis, and Insights by Chartered Professionals
Perkinelmer, Inc. (XNYS:PKI) In-Depth Stock/Fundamental/Options Analysis Today
Primary Facts
PKI
Name:
PERKINELMER, INC. (XNYS:PKI)
Sector:
253.78M
Industry:
Diagnostics & Research
CEO:
Mr. Prahlad Singh
Total Employees:
16,700
Our Technological Advancement Rating
Our Rating:
D
Technological advancement compared to industry is -154.53% lower
ANALYSIS OF ALL CRITICAL FACTORS & RISKS RELATED TO THE STOCK & FUNDAMENTAL/LONG-TERM ANALYSIS OF PERKINELMER, INC.(PKI) AS PER DATA ANALYSIS OF LAST 3 YEARS AND COMPARISON WITH COMPETITORS/PEERS, AND DIAGNOSTICS & RESEARCH INDUSTRY. DATE: 07/09/2022
Primary Targets/Price Insights
Previous Close ($) :
134.59
One Month Price Target:
$135.45
Six Month Price Target :
$139.75
Likely Price in One Year's Time:
Ticker:
$144.92
Likely Trading Range Today Under (Normal Volatility)
$134.2
Price Upper limit ($) :
$135.18
Price Lower limit ($) :
Crash Risk Prep/Key Price Levels (High Volatility/Risk)
Price, as per data analysis, isn't likely to fall below:
Today:
$128.75
This week:
$121.52
This month :
$108.45
Other Primary facts
Market Cap:
16.69B
Market Cap Classification:
Mid Cap
Number of Shares
IPO Date:
126.22M
Best/Worst Daily Performance (Last 3+ Years)
Highest Daily Appreciation:
9.52%
-9.63%
Worst Daily Decline:
Our Options Trading Entry Points
Iron Condor entry points for options expiring in 1 week's time
Low risk (<2%) entry points
Buy Call:
Sell Call:
Buy Put:
Sell Put:
$161.69
$149.14
$107.49
$120.04
Medium risk (<10%) entry points
Buy Call
Sell Call
$145.06
Buy Put:
Sell Put:
$142.38
$124.09
$126.80
These entry points can be used for other strategies, such as butterflies, straddles, etc.
Risk-Adjusted returns (Sharpe Ratio) of
PKI
Sharpe Ratio:
3.07%
Comparison:
PKI, is amongst the top 40% stocks with highest risk-adjusted returns
Sharpe ratio is 22.09% higher than the industry
& ratio is 34.88% higher than the market/S&P 500 average
Average Returns/Yield of
PKI
Daily returns:
0.07%
Weekly returns:
0.37%
Monthly returns:
1.50%
Yearly returns:
27.92%
Comparison of returns:
Average annual returns/yield (last 3 years) is -35.55% below industry average
Classification:
PKI, is amongst the top 40% highest yielding stocks in terms of daily returns
Results of T-Test of Returns:
0.55
Statistical test of Returns:
PKI has yielded returns statistically similar to the market
Volatility (measured by Standard Deviation)
Daily Volatility:
2.15%
Weekly Volatility:
4.81%
Monthly Volatility:
9.62%
Yearly Volatility:
33.32%
Volitlilty of last five days (Measured by Standard Deviation)
Average Volatility of this Week:
0.48%
Volatility in last five trading days has been -77.54% below long-term volatility
Value at Risk Analysis (VaR)
Daily VaR:
-4.34%
Weekly VaR:
-9.71%
Monthly VaR:
-19.42%
How Much Can the price of
PKI
Decline in a Recession?
Likely price decline in a recession:
Base case (decline):
-16%
Worst case (decline):
-67.27%
This translates to price declining to:
$112.64
This translates to price declining to:
$44.05
Severe Crash Probability
Risk of crash in next 6/12 months: High (50-70%)
What is Value at Risk (VaR)?
Risk Fundamentals
PKI is a 37.06% riskier investment compared to the market/S&P 500 & is 17.42% riskier than Nasdaq (IXIC)
Risk (measured by volatility) is -44.29% below industry average
Overall, it is amongst the top 50% most risky stocks
Beta Examination of
PKI
Beta in relation to market/S&P 500--1.14
Expected beta in 1 year's time:
0.799
Expected beta in 3 year's time:
1.13
Unlevered (debt free) Beta:
0.759
Beta in relation to Nasdaq (XNAS):
0.719
Beta in relation to all global stocks::
0.535
Beta Comparison & Analysis
Beta of competitors/peers::
1.017
Beta is 12.27% higher than peers
Average Industry Beta:
1.181
Beta is -3.34% below industry average
Sustainable Growth Rate Analysis
Sustainable growth rate for this stock/firm:
16.06%
Sustainable growth rate is -69.59% below industry average
Alpha provided | Alpha Analysis
Alpha provided:
0.070
Alpha is -57.89% below industry average alpha yield
Alpha is 447% higher than market/& is unsustainably high
Analysis of Cost of Capital of
PKI
Equity cost of capital:
0.110
Equity cost of capital is -2.41% below industry mean WACC
Unlevered (without debt) cost of capital:
7.30%
Before-tax cost of debt:
2.31%
After-tax cost of debt:
1.82%
Overall debt rating:
Highest AAA investment grade
Weighted average cost of capital (WACC):
1.82%
WACC is -9.28% below industry mean WACC
Key Per-Share Metrics & Analysis
Revenue per share:
$39.76
Revenue growth rate per share of (3Y):
2.36
Annual revenue growth rate is -45.24% below industry average
EPS:
$6.20
Expected Annual growth rate of EPS (3Y):
58.03%
Expected future EPS growth rate is 116.18% higher than the Diagnostics & Research industry
Free cash flow (FCF) per share:
$8.65
Balance sheet equity growth per share: -0.20%
Equity growth rate per share is -88.74% lower than the industry
Debt per share
$39.96
EBITDA per share
$12.21
Valuation Analysis Today of
PKI
P/E Ratio:
24.81
P/E Ratio of Competitors/Peers:
28.21
P/E ratio is -12.08% lower than main peers & is -33.28% lower than the industry
Stock price/value with industry average P/E ratio: $230.49
PKI is -41.61% undervalued if valued using industry average P/E ratio
Share value as per dividend discount (DDM) model: $17.48
Present value of the expected future dividends only: $2.55
P/S (Price to Sales ratio):
3.38
Price to sales ratio is -64.38% below the industry mean
P/B (Price to book value ratio):
2.36
Price to free cash flow: 15.56
-
Net income growth rate (3Y):
144.90%
Net income growth rate is -163.40% lower than the industry average net income growth rate
Dividend Analysis
Dividend payout rate: 1.21%
Dividend yeild: 0.21%
Previous Dividend: $0.07
Previous adjusted dividend: $0.07
Previous Dividend: $0.28
-
-
Average dividend payment (long-term): $0.07
Average dividend increase/decrease (growth rate) % per period: 0.00%
Expected next dividend payment date: 08/11/2022
Expected next dividend record date: 21/07/2022
Expected next dividend declaration date: 27/07/2022
Previous dividend payment date: 13/05/2022
Previous dividend record date: 22/04/2022
Previous dividend declaration date: 28/04/2022
Dividend History:
2022-04-21--$0.07
2021-10-21--$0.07
2021-04-15--$0.07
2022-01-20--$0.07
2021-07-15--$0.07
2021-01-21--$0.07
-
In-depth Debt & Leverage Analysis
Debt to equity ratio:
70.19%
Net debt to equity ratio:
60.92%
Debt to assets ratio:
33.97%
Net debt to assets ratio:
29.48%
Debt-to-asset ratio is -30.09% below industry average
Ability to repay debt:
Interest coverage ratio:
13.24
Interest coverage ratio is -147.21% less than industry average
Looking forward:
Debt growth rate:
-4.02%
Annual debt growth is -104% lower than industry average debt growth rate
Debt repayment rate in last quarter: 5.98%
Analysis of Key Statistics
Correlation of price movement with the market:
0.595
Statistical significance of correlation:
PKI has a statistically significant correlation with the market
Average Correlation of the industry with the market:
0.488
Stock price is 21.97% more correlated with the market, compared to the industry average correlation
R Squared (percentage of price movement explained by movement of the market):
0.488
Correlation of price movement with Nasdaq (^IXIC):
-0.017
Covariance of price movement with the market:
-0.021
Kurtosis
2.113
Returns are more concentrated around the mean (platykurtic), compared to a normal distribution
Skewness of returns:
-0.265
Returns are, approximately, symmetrical
Fundamental Analysis & Dupont Analysis of
PKI
Gross Profit Margin Ratio:
219%
Operating Profit Margin Ratio:
22.30%
Operating profit margin is -119.83% lower than the industry
Net Profit Margin Ratio:
219%
Effective Tax Rate:
28.23%
Effective tax rate is 47.09% higher than the industry
Dupont Method
Net Profit Margin
Return on Equity Ratio (ROE):
×
ROA
=
×
10.16%
Return on equity (ROE) is -51.66% lower than the industry
Financial Leverage
Asset Turnover Ratio (ROA):
4.92%
Return on assets (ROA) is -101.82% lower than the industry
Financial Leverage:
1.5x
Current Ratio:
1.94
Current ratio is -60.90% below industry average
Cash Conversion Cycle (days):
23.3
Cash conversion cycle is -52.97% below industry average
The remaining useful life of property plant & equipment is: 3.9 years
Stock based compensation to net income ratio:
2.09%
In-depth Efficiency Analysis
Revenue generated per employee:
300.5K
Each employee generates -19% less revenue than industry average revenue per employee
EBITDA generated per employee:
92.3K
Each employee generates 207% more EBITDA than industry average revenue per employee
Profit generated per employee:
43.7K
Each employee generates 173% more net income/profit than industry average revenue per employee
Free cash flow (FCF) generated per employee:
15.2K
Each employee generates -798% less free cash flow than industry average revenue per employee
Assets/Capital per employee
742.2K
Each employee generates -798% less free cash flow than industry average revenue per employee
Research & Development (R&D) Analysis
Research & development (R&D) investment growth rate-- 8.48%
Growth rate in R&D investment/expenditure is -570.92% lower than the industry
Competitors/Peer firms of
PKI
STERIS PUBLIC LIMITED COMPANY (XNYS:STE)
WATERS CORPORATION (XNYS:WAT)
THE COOPER COMPANIES, INC. (XNYS:COO)
BIO-RAD LABORATORIES, INC. (XNYS:BIO)
Catalent, Inc. (XNYS:CTLT)
QUEST DIAGNOSTICS INCORPORATED (XNYS:DGX)
ZIMMER BIOMET HOLDINGS, INC. (XNYS:ZBH)
Fresenius Medical Care AG & Co KGaA (XNYS:FMS)
LABORATORY CORPORATION OF AMERICA HOLDINGS (XNYS:LH)
Current Analyst Ratings
Strong buy�13%
Buy�8%
Hold�29%
Sell�8%
Strong sell�0%
Overall analyst sentiment is: Hold
Income Statement
Period:
TTM
Date:
4/3/22
Revenue:
5.02B
Cost of Revenue:
Gross Profit:
R&D Expense
General & Admin Expenses:
Selling, General & Admin Expenses
Sales and Marketing Expenses
Other Expenses :
Operating Expenses :
Cost & Expenses :
Interest Income:
Interest Expenses:
Depreciation & Amortization:
EBITDA:
Operating Income:
Other Income Expenses:
Income Before Tax:
Income Tax Expense:
Net Income:
Balance Sheet
Date:
Calendar Year:
Period:
Cash & Cash Equivalents:
Short Term Investments:
Cash & Short Term Investments:
Net Receivables:
Inventory:
Other Current Assets:
Total Current Assets:
PP&E:
Goodwill:
Intangible Assets:
Long Term Investments:
Tax Assets:
Other Non-Current Assets:
Total Non-Current Assets:
Other Assets:
Total Assets:
Accounts Payable:
Short Term Debt:
Tax Payables:
Deferred Revenue:
Other Current Liabilities:
Total Current Liabilities:
Long Term Debt:
Other Non-Current Liabilities:
Total Non Current Liabilities:
Other Liabilities:
Total Liabilities:
Common Stock:
Retained Earnings:
Accumulated Other Comprehensive Loss:
Other Total Stockholders' Equity:
Total Stockholders' Equity:
Total Liabilities and Stockholders' Equity:
Total Investments:
Total Debt:
Net Debt:
2.27B
2.75B
291.36M
-
1.31B
-
-
1.60B
2.43M
116.39M
407.87M
1.54B
1.12B
729.81M
1.02B
287.06M
729.81M
Statement of Cash Flow
Date:
Period:
120.05M
Differed Income Tax :
-
Stock Based Compensation :
15.26M
Change in Working Capital :
- 74072.00K
Accounts Receivables:
69.07M
Other Working Capital:
-
Other Non-Cash Items:
45.01M
Net Cash Provided by Operating Activities:
283.22M
Investments in PP&E:
-
Net Acquisitions:
- 3880.00K
Purchases of Investments:
- 22995.00K
Sales/Maturities of Investments:
Other Investing Activities:
Net Cash Used for Investing Activities:
Debt Repayment:
Common Stock Issued:
Common Stock Repurchased:
Dividend Paid:
Other Financing Activities:
Net Cash Used Provided by Financing Activities:
Effect of FOREX on Changes in Cash:
Net Changes in Cash:
Cash at End of Period:
Cash at Beginning of Period:
Operating Cash Flow:
Capital Expenditure:
Free Cash Flow (FCF):
4/3/22
2022
Q1
669.76M
-
669.76M
941.72M
645.92M
197.11M
2.45B
749.00M
7.37B
3.94B
-
-
334.79M
12.39B
-
14.85B
376.69M
3.73M
-
-
882.63M
1.26B
5.04B
-
6.40B
-
7.66B
126.14M
4.59B
- 246719.0K
2.72B
April 3, 2022 at 6:00:00 AM
3.88B
7.19B
14.85B
-
5.05B
4.4B
-
- 29431.00K
- 56306.00K
- 321064.00K
-
- 55592.00K
- 8837.00K
220.64M
- 164858.00K
- 10636.00K
51.42M
670.75M
619.34M
283.22M
- 29431.00K
253.78M
Our Proprietary Portfolio Rating
Our Rating:
D
Price Forecast/Expected Price in Next 5 Years of
PKI
2023
2024
2025
2026
2027
$145.64
$237.35
$255.57
$275.17
$296.29